Roles > EC 1.9.3.1 (cytochrome c oxidase) inhibitor
Page last updated: 2024-08-05 14:40:30
EC 1.9.3.1 (cytochrome c oxidase) inhibitor
An EC 1.9.3.* (oxidoreductase acting on donor heme group, oxygen as acceptor) inhibitor that interferes with the action of cytochrome c oxidase (EC 1.9.3.1).
ChEBI ID: 38500
Members (3)
Research
Studies (30,861)
| Timeframe | Studies, Drugs with This Role(%) | All Drugs % |
|---|
| pre-1990 | 14,481 (46.92) | 18.7374 |
| 1990's | 3,383 (10.96) | 18.2507 |
| 2000's | 5,553 (17.99) | 29.6817 |
| 2010's | 5,998 (19.44) | 24.3611 |
| 2020's | 1,446 (4.69) | 2.80 |
Study Types
| Publication Type | Studies, Drugs with this Role (%) | All Drugs (%) |
|---|
| Trials | 715 (2.14%) | 5.53% |
| Reviews | 1,781 (5.33%) | 6.00% |
| Case Studies | 492 (1.47%) | 4.05% |
| Observational | 73 (0.22%) | 0.25% |
| Other | 30,336 (90.83%) | 84.16% |
Protein Targets (6)
Inhibition Measurements